InvestorsHub Logo
Followers 17
Posts 2328
Boards Moderated 0
Alias Born 10/26/2017

Re: FastMny post# 48924

Wednesday, 05/08/2019 8:47:42 PM

Wednesday, May 08, 2019 8:47:42 PM

Post# of 83375
Mona's compensation is 5 years worth of options and warrants accumulation. There was a $7.9M share based comp for the Q and most of it is Mona's. Also, this is a non-cash recording and it is a positive entry in the cash flow. The company needs to recognize the difference between the value of the warrants and option to the current SP. THIS IS A ONE TIME ALSO FOR MONA because he is gone. So divide that amount by 5 years and that's a measure of CVSI/His success per year for the last 5 years. Proof of this is that the operating cash was positive $761K despite of a very high opex number. This goes to show the financial strength of the operation.
In addition to the share base comp, R&D was increased 5+X for developing new products, new production methods and clinical trials. Head count was doubled yoy and the sales and production departments are being fully automized. Yet the cash from operations was positive and the cash available increased. Demonstrating again the financial strength of the company.

Also: JD said "Revenues will be lumpy going forward, UPWARD lumpy"

I will have to take a look at the transcript for confirmation but the report looks acceptable to me and the outlook seems great as expected.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News